Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| CorMedix Inc.CRMD · Entity 5280 | Director | January 26, 2026 | January 28, 2026 |
| ORAGENICS INCOGEN · Entity 8495 | Director | December 11, 2025 | December 15, 2025 |
| PALATIN TECHNOLOGIES INCPTN · Entity 7649 | Director | August 03, 2026 | August 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
CorMedix Inc.
Report date January 26, 2026 · Filed January 28, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 70,703 |
Reported balance
After 2026-01-26 transaction · row 1
1 source rowRow 1 · 2026-01-26 · Grant · Acquired 30,453 · Balance 70,703 F1: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date.
ORAGENICS INC
Report date December 11, 2025 · Filed December 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Non-Employee Director Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.93 · Expires 2035-12-11 | Direct | 125,000 |
Reported balance
After 2025-12-11 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2025-12-11 · Grant · Acquired 125,000 · Balance 125,000 F1: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. |
Filing footnotes · ownership attribution and instrument terms
F1: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant.
PALATIN TECHNOLOGIES INC
Report date August 03, 2026 · Filed August 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| StockOption (Right toBuy)SEC Table II · derivative / convertible security · Conversion / exercise price $7.70 · Expires 2037-08-03 | Direct | 25,769 |
Reported balance
After 2026-08-03 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-08-03 · Other · Acquired 2,200 · Balance 25,769 F1: Stock Option granted under the 2011 Stock Incentive Plan as amended. The option vests as to 50% on August 3, 2027 and as to the remaining 50% on August 3, 2028. The option was granted by the Compensation Committee on August 3, 2026, and there was no impediment to the grant of option. |
Filing footnotes · ownership attribution and instrument terms
F1: Stock Option granted under the 2011 Stock Incentive Plan as amended. The option vests as to 50% on August 3, 2027 and as to the remaining 50% on August 3, 2028. The option was granted by the Compensation Committee on August 3, 2026, and there was no impediment to the grant of option.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 03, 2026 Filed Aug 5, 2026 20:30 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | OtherStockOption (Right toBuy) · Derivative | 2,200 | $0.00 Strike: $7.70 | $0.00 |
DisclosureSEC source: 0001493152-26-036186 · ownership.xml · derivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,769 Underlying: Common Stock · 2,200 shares Expires 2037-08-03 F1 · derivative.exercise_date: Stock Option granted under the 2011 Stock Incentive Plan as amended. The option vests as to 50% on August 3, 2027 and as to the remaining 50% on August 3, 2028. The option was granted by the Compensation Committee on August 3, 2026, and there was no impediment to the grant of option. Read SEC document |
| January 26, 2026 Filed Jan 28, 2026 02:30 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantCommon Stock | 30,453 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-26-008475 · ownership.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 70,703 F1 · price: These shares represent restricted stock units issued on January 26, 2026. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 26, 2027, subject to continued service on the vesting date. Read SEC document |
| December 30, 2025 Filed Jan 3, 2026 02:30 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative | 20,000 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0001213900-26-000712 · ownership.xml · derivative · entry 3 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2032-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: These options were granted on 2/22/2022. These options are fully vested. Read SEC document |
| December 30, 2025 Filed Jan 3, 2026 02:30 UTC | CorMedix Inc. CRMD · Entity 5280 | SaleCommon Stock | 20,000 | $13.00 | $260,000.00 |
DisclosureSEC source: 0001213900-26-000712 · ownership.xml · nonDerivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,250 Read SEC document |
| December 30, 2025 Filed Jan 3, 2026 02:30 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionCommon Stock | 20,000 | $4.03 | $80,600.00 |
DisclosureSEC source: 0001213900-26-000712 · ownership.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 11, 2025 Filed Dec 15, 2025 21:25 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantNon-Employee Director Option (Right to Buy) · Derivative | 125,000 | $0.00 Strike: $0.93 | $0.00 |
DisclosureSEC source: 0001304773-25-000003 · primary_doc.xml · derivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 125,000 Underlying: Common Stock · 125,000 shares Expires 2035-12-11 F1 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. F1 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. F1 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. F1 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended, pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 22:00 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantStock Option (Right to Buy) · Derivative | 1,200 | $0.00 Strike: $21.38 | $0.00 |
DisclosureSEC source: 0001493152-25-027267 · ownership.xml · derivative · entry 4 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 25,999 Underlying: Common Stock · 1,200 shares Expires 2026-12-09 F4 · derivative.exercise_date: Stock Options granted under the 2011 Stock Incentive Plan, the option vests as to 50% on December 9, 2026 and as to the remaining 50% on December 9, 2027. The options were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of options. F4 · derivative.expiration_date: Stock Options granted under the 2011 Stock Incentive Plan, the option vests as to 50% on December 9, 2026 and as to the remaining 50% on December 9, 2027. The options were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of options. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 22:00 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantStock Option (Right to Buy) · Derivative | 1,200 | $0.00 Strike: $21.38 | $0.00 |
DisclosureSEC source: 0001493152-25-027267 · ownership.xml · derivative · entry 3 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 24,799 Underlying: Common Stock · 1,200 shares Expires 2035-12-09 F3 · derivative.exercise_date: Stock Options granted under the 2011 Stock Incentive Plan, the option vests on December 9,2026, and in the event that the director does not serve until December 31, 2026, is prorated based on the period of service at the rate of 1/12 per month on the last day of each month, starting on January 31, 2026. The options were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of the options. F3 · derivative.expiration_date: Stock Options granted under the 2011 Stock Incentive Plan, the option vests on December 9,2026, and in the event that the director does not serve until December 31, 2026, is prorated based on the period of service at the rate of 1/12 per month on the last day of each month, starting on January 31, 2026. The options were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of the options. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 22:00 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-027267 · ownership.xml · nonDerivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 14,081 F2 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest as to 50% on December 9, 2026 and as to the remaining 50% on December 9, 2027. The restricted share units were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of the restricted stock units. F2 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest as to 50% on December 9, 2026 and as to the remaining 50% on December 9, 2027. The restricted share units were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of the restricted stock units. Read SEC document |
| December 09, 2025 Filed Dec 11, 2025 22:00 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantCommon Stock | 1,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-25-027267 · ownership.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,081 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on December 9, 2026. The restricted share units were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of the restricted stock units. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on December 9, 2026. The restricted share units were granted by the Compensation Committee on December 9, 2025, and there were no impediments to the grant of the restricted stock units. Read SEC document |
| September 12, 2025 Filed Sep 17, 2025 01:45 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionStock Option (Right to Buy Common Stock) · Derivative | 10,000 | $0.00 Strike: $3.55 | $0.00 |
DisclosureSEC source: 0001213900-25-088337 · ownership.xml · derivative · entry 3 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 10,000 shares Expires 2034-03-05 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: These options were granted on 3/5/2024. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| September 12, 2025 Filed Sep 17, 2025 01:45 UTC | CorMedix Inc. CRMD · Entity 5280 | SaleCommon Stock | 10,000 | $13.13 | $131,300.00 |
DisclosureSEC source: 0001213900-25-088337 · ownership.xml · nonDerivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,250 F1 · price: This transaction was executed in multiple trades at prices ranging from $13.00 to $13.25. The price reported in Column 4 is a weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transactions were effected. Read SEC document |
| September 12, 2025 Filed Sep 17, 2025 01:45 UTC | CorMedix Inc. CRMD · Entity 5280 | Exercise / conversionCommon Stock | 10,000 | $3.55 | $35,500.00 |
DisclosureSEC source: 0001213900-25-088337 · ownership.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,250 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:35 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | PurchaseSeries I warrants · Derivative | 363,636 | $0.00 Strike: $0.11 | $0.00 |
DisclosureSEC source: 0001654954-25-007105 · section16.xml · derivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 420,016 Underlying: Common Stock · 363,636 shares Expires not disclosed F1 · price: Each share of Series D Convertible Preferred Stock has a stated value of $100 per share, and is convertible to common stock at an initial conversion price of $0.11 per share, for a total of 181,818 shares of common stock. The Series D Preferred Stock and Series I common stock purchase warrants were sold at a combined offering price of $0.11 per share of common stock obtainable upon conversion of the Series D Convertible Preferred Stock. F2 · derivative.exercise_date: The Series I warrants are exercisable on or after the date that approval is obtained from the Issuer's stockholders as may be required by the NYSE American (or any successor entity) (the "Stockholder Approval Date"), and will expire on the five-year anniversary of the Stockholder Approval Date, subject to the terms and conditions contained in such Series I warrant. F2 · derivative.expiration_date: The Series I warrants are exercisable on or after the date that approval is obtained from the Issuer's stockholders as may be required by the NYSE American (or any successor entity) (the "Stockholder Approval Date"), and will expire on the five-year anniversary of the Stockholder Approval Date, subject to the terms and conditions contained in such Series I warrant. Read SEC document |
| June 13, 2025 Filed Jun 17, 2025 20:35 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | PurchaseSeries D Preferred Stock | 200 | $20,000.00 | $4,000,000.00 |
DisclosureSEC source: 0001654954-25-007105 · section16.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 224,112 F1 · shares: Each share of Series D Convertible Preferred Stock has a stated value of $100 per share, and is convertible to common stock at an initial conversion price of $0.11 per share, for a total of 181,818 shares of common stock. The Series D Preferred Stock and Series I common stock purchase warrants were sold at a combined offering price of $0.11 per share of common stock obtainable upon conversion of the Series D Convertible Preferred Stock. Read SEC document |
| January 17, 2025 Filed Jan 23, 2025 02:10 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001213900-25-005674 · ownership.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,250 F1 · price: These shares represent restricted stock units issued on January 17, 2025. Each restricted stock unit represents the right to receive one share of CorMedix Inc. common stock. These restricted stock units will vest in full on January 17, 2026, subject to continued service on the vesting date. Read SEC document |
| December 06, 2024 Filed Dec 9, 2024 23:07 UTC | ORAGENICS INC OGEN · Entity 8495 | SaleCommon Stock | 66 | $0.36 | $23.76 |
DisclosureSEC source: 0001493152-24-049325 · ownership.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,623 Read SEC document |
| September 19, 2024 Filed Sep 21, 2024 01:15 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantNon-Employee Director Option (Right to Buy) · Derivative | 65,000 | $0.00 Strike: $0.48 | $0.00 |
DisclosureSEC source: 0001493152-24-037728 · ownership.xml · derivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2034-09-19 F1 · security: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. F1 · shares: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. F1 · derivative.exercise_date: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. F1 · balance_after: Represents an award of options to purchase shares of the Company's Common Stock under the Company's 2021 Equity Incentive Plan, as amended pursuant to the Company's non-employee director compensation program. The options vest immediately. The option exercise price is the Company's closing price on the date of grant. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 20:31 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantStock Option (Right to Buy) · Derivative | 17,000 | $0.00 Strike: $183.00 | $0.00 |
DisclosureSEC source: 0001654954-24-009001 · section16.xml · derivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,780 Underlying: Common Stock · 17,000 shares Expires 2034-06-04 F2 · derivative.exercise_date: The option vests on June 4, 2025, and in the event that the director does not serve until June 30, 2025, is prorated based on the period of service at the rate of 1/12 per month on the last day of each month, starting on July 31, 2024. The options were granted by the Compensation Committee on June 4, 2024, which grant was subject to certification by the Chief Financial Officer that the shareholders had increased the shares reserved under the 2011 Stock Incentive Plan, and that there were no impediments to the grant of the options. The required certification was made on July 15, 2024. Read SEC document |
| July 15, 2024 Filed Jul 16, 2024 20:31 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-24-009001 · section16.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,294 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 4, 2025. The restricted share units were granted by the Compensation Committee on June 4, 2024, which grant was subject to certification by the Chief Financial Officer that the shareholders had increased the shares reserved under the 2011 Stock Incentive Plan, and that there were no impediments to the grant of the options. The required certification was made on July 15, 2024. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 15:14 UTC Amendment | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantStock Option (Right to Buy) · Derivative | 17,000 | $0.00 Strike: $1.83 | $0.00 |
DisclosureSEC source: 0001654954-24-009045 · section16.xml · derivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 57,780 Underlying: Common Stock · 17,000 shares Expires 2034-06-04 F2 · derivative.exercise_date: The option vests on June 4, 2025, and in the event that the director does not serve until June 30, 2025, is prorated based on the period of service at the rate of 1/12 per month on the last day of each month, starting on July 31, 2024. The options were granted by the Compensation Committee on June 4, 2024, which grant was subject to certification by the Chief Financial Officer that the shareholders had increased the shares reserved under the 2011 Stock Incentive Plan, and that there were no impediments to the grant of the options. The required certification was made on July 15, 2024. Read SEC document |
| July 15, 2024 Filed Jul 17, 2024 15:14 UTC Amendment | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantCommon Stock | 12,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-24-009045 · section16.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,294 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 4, 2025. The restricted share units were granted by the Compensation Committee on June 4, 2024, which grant was subject to certification by the Chief Financial Officer that the shareholders had increased the shares reserved under the 2011 Stock Incentive Plan, and that there were no impediments to the grant of the options. The required certification was made on July 15, 2024. Read SEC document |
| March 05, 2024 Filed Mar 20, 2024 20:24 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 30,000 | $0.00 Strike: $3.55 | $0.00 |
DisclosureSEC source: 0000899140-24-000322 · form4.xml · derivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2034-03-05 F1 · derivative.exercise_date: These options were granted on 3/5/2024. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| December 15, 2023 Filed Dec 18, 2023 21:47 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 3,000 | $3.30 | $9,900.00 |
DisclosureSEC source: 0000929638-23-003434 · form4.xml · nonDerivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,250 Read SEC document |
| December 14, 2023 Filed Dec 18, 2023 21:47 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 3,000 | $3.45 | $10,350.00 |
DisclosureSEC source: 0000929638-23-003434 · form4.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,250 Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 22:02 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | SaleCommon Stock | 1 | $2.46 | $2.46 |
DisclosureSEC source: 0001654954-23-015219 · section16.xml · nonDerivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,074 Read SEC document |
| December 04, 2023 Filed Dec 6, 2023 22:02 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | SaleCommon Stock | 199 | $2.48 | $493.52 |
DisclosureSEC source: 0001654954-23-015219 · section16.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,075 Read SEC document |
| August 08, 2023 Filed Aug 10, 2023 20:30 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantCommon Stock | 25,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001493152-23-027577 · ownership.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,689 F1 · shares: Represents an award of restricted stock pursuant to the Company's non-employee director compensation program under the Company's 2021 Equity Incentive Plan with 20,000 shares vesting immediately and 5,000 shares vesting in six (6) months. F2 · balance_after: Reflects adjustments made in connection with the 1-for-60 reverse stock split of the Issuer's common stock which became effective on January 23, 2023 Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 21:00 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantStock Option (Right to Buy) · Derivative | 16,000 | $0.00 Strike: $2.19 | $0.00 |
DisclosureSEC source: 0001654954-23-008312 · section16.xml · derivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,000 Underlying: Common Stock · 16,000 shares Expires 2033-06-20 F2 · derivative.exercise_date: The option vests on June 30, 2024, and in the event that the director does not serve until June 30, 2024, is prorated based on the period of service at the rate of 1/12 per month on the last day of each month, starting on July 31, 2023. Read SEC document |
| June 20, 2023 Filed Jun 22, 2023 21:00 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantCommon Stock | 10,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-23-008312 · section16.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,807 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 20, 2024. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 20, 2024. Read SEC document |
| May 17, 2023 Filed May 17, 2023 23:08 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantCommon Stock | 3,000 | $4.33 | $12,979.80 |
DisclosureSEC source: 0000929638-23-001520 · form4.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,250 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.31 to $4.34, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| May 17, 2023 Filed May 18, 2023 21:05 UTC Amendment | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 3,000 | $4.33 | $12,979.80 |
DisclosureSEC source: 0000929638-23-001531 · form4.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,250 F1 · kind: On May 17, 2023, the reporting person filed a Form 4 which inadvertently included Transaction Code "A". The original Form 4 should have indicated Transaction Code "P". The reporting person has filed this amendment to restate the transaction with the correct Transaction Code. F2 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.31 to $4.34, inclusive. The reporting person undertakes to provide CorMedix Inc., any security holder of CorMedix Inc., or the staff at the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote to this Form 4. Read SEC document |
| January 14, 2023 Filed Jan 18, 2023 23:59 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 20,000 | $0.00 Strike: $4.43 | $0.00 |
DisclosureSEC source: 0001213900-23-003550 · ownership.xml · derivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-01-14 F1 · derivative.exercise_date: These options were granted on 1/14/2023. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| December 21, 2022 Filed Dec 23, 2022 22:30 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | SaleCommon Stock | 200 | $2.97 | $594.00 |
DisclosureSEC source: 0001654954-22-016941 · section16.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,420 Read SEC document |
| July 29, 2022 Filed Aug 2, 2022 20:32 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantNon-Employee Director Option (Right to Buy) · Derivative | 220,000 | $0.00 Strike: $0.36 | $0.00 |
DisclosureSEC source: 0001493152-22-021013 · ownership.xml · derivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 220,000 Underlying: Common Stock · 220,000 shares Expires 2032-07-29 F1 · security: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022. F1 · shares: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022. F1 · derivative.underlying_shares: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022. F1 · balance_after: Represents an award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2021 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, July 29, 2022. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 23:31 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantStock Option (Right to Buy) · Derivative | 128,000 | $0.00 Strike: $0.29 | $0.00 |
DisclosureSEC source: 0001654954-22-008780 · section16.xml · derivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,000 Underlying: Common Stock · 128,000 shares Expires 2032-06-22 F2 · derivative.exercise_date: The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2022. Read SEC document |
| June 22, 2022 Filed Jun 24, 2022 23:31 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantCommon Stock | 73,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-22-008780 · section16.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 991,519 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 22, 2023. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 22, 2023. Read SEC document |
| February 22, 2022 Filed Feb 23, 2022 21:20 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 20,000 | $0.00 Strike: $4.03 | $0.00 |
DisclosureSEC source: 0001213900-22-008959 · doc4.xml · derivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2032-02-22 F5 · derivative.exercise_date: These options were granted on 2/22/2022. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| December 16, 2021 Filed Dec 17, 2021 22:04 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantNon-Employee Director Option (Right to Buy) · Derivative | 75,000 | $0.00 Strike: $0.49 | $0.00 |
DisclosureSEC source: 0001493152-21-031888 · ownership.xml · derivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 75,000 Underlying: Common Stock · 75,000 shares Expires 2031-12-16 F1 · security: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. F1 · shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. F1 · derivative.underlying_shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. F1 · balance_after: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, December 16, 2021. Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 19:48 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantCommon Stock | 10,000 | $0.62 | $6,200.00 |
DisclosureSEC source: 0001654954-21-007518 · section16.xml · nonDerivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 786,518 Read SEC document |
| June 30, 2021 Filed Jul 1, 2021 19:48 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantCommon Stock | 10,000 | $0.62 | $6,150.00 |
DisclosureSEC source: 0001654954-21-007518 · section16.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 776,518 Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 14:55 UTC Amendment | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | PurchaseCommon Stock | 10,000 | $0.62 | $6,200.00 |
DisclosureSEC source: 0001654954-21-007562 · section16.xml · nonDerivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 786,518 F1 · kind: Amended to reflect open market purchases of non-derivative security. Read SEC document |
| June 30, 2021 Filed Jul 2, 2021 14:55 UTC Amendment | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | PurchaseCommon Stock | 10,000 | $0.62 | $6,150.00 |
DisclosureSEC source: 0001654954-21-007562 · section16.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 776,518 F1 · kind: Amended to reflect open market purchases of non-derivative security. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 21:01 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantStock Option (Right to Buy) · Derivative | 128,000 | $0.00 Strike: $0.55 | $0.00 |
DisclosureSEC source: 0001654954-21-007253 · section16.xml · derivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 128,000 Underlying: Common Stock · 128,000 shares Expires 2031-06-22 F2 · derivative.exercise_date: The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2021. Read SEC document |
| June 22, 2021 Filed Jun 24, 2021 21:01 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantCommon Stock | 77,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-21-007253 · section16.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 766,518 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 22, 2022. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 22, 2022. Read SEC document |
| February 18, 2021 Filed Feb 19, 2021 21:35 UTC | ORAGENICS INC OGEN · Entity 8495 | GrantNon-Employee Director Option (Right to Buy) · Derivative | 160,000 | $0.00 Strike: $1.20 | $0.00 |
DisclosureSEC source: 0001493152-21-004422 · ownership.xml · derivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 160,000 Underlying: Common Stock · 160,000 shares Expires 2031-02-18 F1 · security: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. F1 · shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. F1 · derivative.underlying_shares: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. F1 · balance_after: Represents an annual award of options pursuant to the Company's non-employee director compensation program to purchase shares of common stock under the Company's 2012 Equity Incentive Plan. The options vest immediately and the exercise price is the closing price on the date of the grant, February 18, 2021. Read SEC document |
| January 11, 2021 Filed Jan 14, 2021 02:32 UTC | CorMedix Inc. CRMD · Entity 5280 | GrantStock Option (Right to Buy Common Stock) · Derivative | 30,000 | $0.00 Strike: $8.32 | $0.00 |
DisclosureSEC source: 0001213900-21-002074 · doc4.xml · derivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,000 Underlying: Common Stock · 30,000 shares Expires 2031-01-11 F1 · derivative.exercise_date: These options were granted on 1/11/2021. The options vest monthly with full vesting on the one year anniversary of the date of grant, subject to continued service on the board. Read SEC document |
| August 12, 2020 Filed Aug 14, 2020 21:29 UTC | CorMedix Inc. CRMD · Entity 5280 | PurchaseCommon Stock | 5,000 | $3.95 | $19,750.00 |
DisclosureSEC source: 0001213900-20-022353 · doc4.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,250 Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 21:02 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantStock option (right to buy) · Derivative | 127,000 | $0.00 Strike: $0.58 | $0.00 |
DisclosureSEC source: 0001654954-20-006793 · section16.xml · derivative · entry 2 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 127,000 Underlying: Common Stock · 127,000 shares Expires 2030-06-16 F2 · derivative.exercise_date: The options vest at the rate of 1/12 per month on the last day of each month, starting on July 31, 2020. Read SEC document |
| June 16, 2020 Filed Jun 18, 2020 21:02 UTC | PALATIN TECHNOLOGIES INC PTN · Entity 7649 | GrantCommon Stock | 73,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001654954-20-006793 · section16.xml · nonDerivative · entry 1 DUNTON ALAN W · CIK 0001304773 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 578,935 F1 · shares: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 16, 2021. F1 · price: Restricted share units granted under the 2011 Stock Incentive Plan, each of which represents the right to receive, without further payment, one share of common stock. The restricted share units vest on June 16, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.